Security key
07725L102
BeOne Medicines Ltd. - Ordinary Shares, par value $0.0001 per share (ONC)
CUSIP: 07725L102
Q2 2025 13F Holders as of 30 Jun 2025
- Type / Class
- Equity / Ordinary Shares, par value $0.0001 per share
- Shares outstanding
- 1,448,978,913
- Total 13F shares
- 34,445,503
- Share change
- -8,062,587
- Total reported value
- $8,338,029,358
- Put/Call ratio
- 94%
- Price per share
- $242.07
- Number of holders
- 240
- Value change
- -$2,097,913,474
- Number of buys
- 118
- Number of sells
- 128
Report period
Q2 2025
Institutions
240
Top holders
10
ONC full security history
Newer quarter: Q3 2025
Previous quarter: Q1 2025
BeOne Medicines Ltd. SEC filings
BeOne Medicines Ltd. company facts
BeOne Medicines Ltd. 13D/G history
Broader feeds
Reporting periods
Holder history for CUSIP 07725L102
Recent filing periods:
Top shareholders of ONC - BeOne Medicines Ltd. - Ordinary Shares, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| HHLR ADVISORS, LTD. |
3/4/5
13D/G
13F
|
10%+ Owner · Company |
4.9%
from 13D/G
|
125,045,741
|
$25,009,148,200 | — | 02 Dec 2024 | |
| BAKER BROS. ADVISORS LP |
13F
3/4/5
|
Company · Director |
0.61%
|
8,799,053
|
$2,394,838,255 | — | 31 Mar 2025 | |
| Capital International Investors |
13F
|
Company |
0.35%
|
5,090,970
|
$1,384,108,227 | — | 31 Mar 2025 | |
| PRIMECAP MANAGEMENT CO/CA/ |
13F
|
Company |
0.35%
|
5,055,504
|
$1,375,956,527 | — | 31 Mar 2025 | |
| BAILLIE GIFFORD & CO |
13F
|
Company |
0.25%
|
3,630,710
|
$988,170,340 | — | 31 Mar 2025 | |
| FMR LLC |
13F
|
Company |
0.24%
|
3,453,576
|
$939,959,904 | — | 31 Mar 2025 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.19%
|
2,713,418
|
$738,512,000 | — | 31 Mar 2025 | |
| Temasek Holdings (Private) Ltd |
13F
|
Company |
0.07%
|
993,752
|
$270,469,482 | — | 31 Mar 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.07%
|
982,161
|
$267,314,760 | — | 31 Mar 2025 | |
| Paradigm Biocapital Advisors LP |
13F
|
Company |
0.05%
|
666,024
|
$181,271,752 | — | 31 Mar 2025 | |
| BlackRock, Inc. |
13F
|
Company |
0.04%
|
582,290
|
$158,481,870 | — | 31 Mar 2025 | |
| Siren, L.L.C. |
13F
|
Individual |
0.03%
|
498,689
|
$135,728,185 | — | 31 Mar 2025 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.03%
|
477,143
|
$129,864,011 | — | 31 Mar 2025 | |
| Capital International, Inc./CA/ |
13F
|
Company |
0.03%
|
437,382
|
$119,042,259 | — | 31 Mar 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.03%
|
411,929
|
$112,115,247 | — | 31 Mar 2025 | |
| PUBLIC INVESTMENT FUND |
13F
|
Company |
0.02%
|
354,385
|
$96,452,965 | — | 31 Mar 2025 | |
| Nuveen, LLC |
13F
|
Company |
0.02%
|
346,451
|
$94,293,569 | — | 31 Mar 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.02%
|
292,787
|
$79,687,892 | — | 31 Mar 2025 | |
| Connor, Clark & Lunn Investment Management Ltd. |
13F
|
Company |
0.02%
|
291,606
|
$79,366,405 | — | 31 Mar 2025 | |
| Artisan Partners Limited Partnership |
13F
|
Company |
0.02%
|
287,400
|
$78,221,658 | — | 31 Mar 2025 | |
| S.c.a. Candriam |
13F
|
Individual |
0.02%
|
285,893
|
$77,811,494 | — | 31 Mar 2025 | |
| Baird Financial Group, Inc. |
13F
|
Company |
0.02%
|
274,396
|
$74,682,359 | — | 31 Mar 2025 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
0.02%
|
223,443
|
$60,814,479 | — | 31 Mar 2025 | |
| FIRST TRUST ADVISORS LP |
13F
|
Company |
0.02%
|
223,186
|
$60,744,533 | — | 31 Mar 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.01%
|
186,910
|
$50,871,295 | — | 31 Mar 2025 | |
| M&G Plc |
13F
|
Company |
0.01%
|
186,031
|
$50,600,432 | — | 31 Mar 2025 | |
| DRIEHAUS CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.01%
|
180,956
|
$49,250,795 | — | 31 Mar 2025 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0.01%
|
171,880
|
$46,780,580 | — | 31 Mar 2025 | |
| Man Group plc |
13F
|
Company |
0.01%
|
153,823
|
$41,866,006 | — | 31 Mar 2025 | |
| Capital Group Private Client Services, Inc. |
13F
|
Company |
0.01%
|
152,156
|
$41,412,298 | — | 31 Mar 2025 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.01%
|
140,574
|
$38,260,026 | — | 31 Mar 2025 | |
| Capital International Sarl |
13F
|
Company |
0.01%
|
139,005
|
$37,832,991 | — | 31 Mar 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.01%
|
138,310
|
$37,643,832 | — | 31 Mar 2025 | |
| TD ASSET MANAGEMENT INC |
13F
|
Company |
0.01%
|
116,104
|
$31,600,026 | — | 31 Mar 2025 | |
| CANADA PENSION PLAN INVESTMENT BOARD |
13F
|
Company |
0.01%
|
109,300
|
$29,748,181 | — | 31 Mar 2025 | |
| Cubist Systematic Strategies, LLC |
13F
|
Company |
0.01%
|
108,998
|
$29,665,956 | — | 31 Mar 2025 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.01%
|
104,466
|
$28,432,511 | — | 31 Mar 2025 | |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
0.01%
|
102,969
|
$28,025,073 | — | 31 Mar 2025 | |
| Burkehill Global Management, LP |
13F
|
Company |
0.01%
|
100,000
|
$27,217,000 | — | 31 Mar 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.01%
|
98,138
|
$26,710,124 | — | 31 Mar 2025 | |
| Iron Triangle Partners LP |
13F
|
Company |
0.01%
|
97,840
|
$26,629,113 | — | 31 Mar 2025 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.01%
|
89,727
|
$24,420,998 | — | 31 Mar 2025 | |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND |
13F
|
Company |
0.01%
|
87,200
|
$23,733,224 | — | 31 Mar 2025 | |
| Jump Financial, LLC |
13F
|
Company |
0.01%
|
82,200
|
$22,372,374 | — | 31 Mar 2025 | |
| VAN ECK ASSOCIATES CORP |
13F
|
Company |
0.01%
|
80,430
|
$21,891,000 | — | 31 Mar 2025 | |
| Mitsubishi UFJ Trust & Banking Corp |
13F
|
Company |
0.01%
|
78,877
|
$21,467,953 | — | 31 Mar 2025 | |
| BNP Paribas Asset Management Holding S.A. |
13F
|
Company |
0.01%
|
78,388
|
$20,960,000 | — | 31 Mar 2025 | |
| Walleye Capital LLC |
13F
|
Company |
0.01%
|
72,747
|
$19,799,551 | — | 31 Mar 2025 | |
| CAPITAL INTERNATIONAL LTD /CA/ |
13F
|
Company |
0%
|
69,492
|
$18,913,638 | — | 31 Mar 2025 | |
| Squarepoint Ops LLC |
13F
|
Company |
0%
|
69,470
|
$18,907,650 | — | 31 Mar 2025 |
Institutional Holders of BeOne Medicines Ltd. - Ordinary Shares, par value $0.0001 per share (ONC) as of Q2 2025
As of 30 Jun 2025,
BeOne Medicines Ltd. - Ordinary Shares, par value $0.0001 per share (ONC) was held by
240 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
34,445,503 shares.
The largest 10 holders included
BAKER BROS. ADVISORS LP, PRIMECAP MANAGEMENT CO/CA/, Capital International Investors, FMR LLC, HHLR ADVISORS, LTD., PRICE T ROWE ASSOCIATES INC /MD/, Temasek Holdings (Private) Ltd, CITADEL ADVISORS LLC, Siren, L.L.C., and BlackRock, Inc..
This page lists
241
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
260
Q2 2025 holders
240
Holder diff
-20
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 Value $ | Q2 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.